Active ingredientFaldaprevirCat. No. P-F001-001CAS 801283-95-4Family · Pharmaceutical analytical standards
Faldaprevir
An inhibitor of the hepatitis C virus NS3/4A protease, which reached phase III trials in 2011; in 2014 its development was stopped because newer hepatitis C treatments had become available. This family brings together the active ingredient and labelled standards.
Did you know?In the SOUND-C2 study it was tested in an interferon-free combination with deleobuvir and ribavirin, with good results in patients with genotype 1b of the virus.
Go to the active ingredient →Active ingredientFaldaprevirCat. No. P-F001-001CAS 801283-95-4
Isotopically labelledFaldaprevir-D3Cat. No. P-F001-002
Isotopically labelledFaldaprevir-d6Cat. No. P-F001-003CAS 2750534-88-2
Isotopically labelledFaldaprevir-d7Cat. No. P-F001-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.